Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Randomized study comparing afatinib with chemotherapy in treatment-naive NSCLC with uncommon EGFR mutations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Sequist, L. V., Yang, J. C.-H., Yamamoto, N., O'Byrne, K., Hirsh, V., Mok, T., Geater, S. L., Orlov, S., Tsai, C.-M., Boyer, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.2806 · Cited by 3,228
Self-citationCross, D. A. E., Ashton, S. E., Ghiorghiu, S., Eberlein, C., Nebhan, C. A., Spitzler, P. J., Orme, J. P., Finlay, M. R. V., Ward, R. A., Mellor, M. J., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0337 · Cited by 2,246
Self-citationWu, Y.-L., Zhou, C., Hu, C.-P., Feng, J., Lu, S., Huang, Y., Li, W., Hou, M., Shi, J. H., Lee, K. Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70604-1 · Cited by 1,978
Park, K., Tan, E.-H., O'Byrne, K., Zhang, L., Boyer, M., Mok, T., Hirsh, V., Yang, J. C.-H., Lee, K. H., Lu, S., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30033-x · Cited by 1,183
Yang, J. C.-H., Sequist, L. V., Geater, S. L., Tsai, C.-M., Mok, T. S. K., Schuler, M., Yamamoto, N., Yu, C.-J., Ou, S.-H. I., Zhou, C., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00026-1 · Cited by 1,002
Structure-based classification predicts drug response in EGFR-mutant NSCLC
Robichaux, J. P., Le, X., Vijayan, R. S. K., Hicks, J. K., Heeke, S., Elamin, Y. Y., Lin, H. Y., Udagawa, H., Skoulidis, F., Tran, H., et al. (2021) · Nature · doi:10.1038/s41586-021-03898-1 · Cited by 490
Kobayashi, Y., & Mitsudomi, T. (2016) · Cancer Science · doi:10.1111/cas.12996 · Cited by 413
Cho, J. H., Lim, S. H., An, H. J., Kim, K. H., Park, K. U., Kang, E. J., Choi, Y. H., Ahn, M. S., Lee, M. H., Sun, J.-M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.00931 · Cited by 358
Goss, G., Tsai, C.-M., Shepherd, F. A., Ahn, M.-J., Bazhenova, L., Crinò, L., de Marinis, F., Felip, E., Morabito, A., Hodge, R., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx820 · Cited by 247
Cited by
Hendriks, L. E. L., Cortiula, F., Martins-Branco, D. A., Mariamidze, E., Popat, S., & Reck, M. (2025) · Annals of Oncology · doi:10.1016/j.annonc.2025.06.007 · Cited by 32
Advances in Targeted Therapy for Non-Small-Cell Lung Cancer: Current Progress and Future Directions
Peshin, S., Takrori, E., Yazji, J. H., Haque, J., Dharia, A. A., Mithani, M. S., Anum, F., Asfeen, U. Z., Couch, J. K., Donovan, M., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311517 · Cited by 17
Leveraging conformational ensembles in allosteric drug discovery
Nussinov, R., Regev, C., & Jang, H. (2026) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2026.01.006 · Cited by 14
Afatinib, Dose Reduction, and Pseudo-Acute Kidney Injury
Nguyen, J. T., Das, D. G., & Shah, C. V. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-25-01219 · Cited by 4
Afatinib-associated pseudo-acute kidney injury
Nguyen, J. T., Das, D. G., & Shah, C. V. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf333 · Cited by 3
Hu, S., Shi, X., Hu, Q., Wang, X., & Zhou, G. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189561 · Cited by 4
Spitaleri, G., Aliaga, P. T., Mariani, G. A., Attili, I., Signore, E. D., Corvaja, C., Napoli, V. M., Cavallone, M., Etessami, J. D., Zhan, Y., et al. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105327 · Cited by 2
Lasering in on Uncommon EGFR Mutations
Kim, S. Y., Politi, K. A., & Goldberg, S. B. (2025) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2025.06.014 · Cited by 2
Liu, X., Stamboulian, M. H., Borgeaud, M., Zhu, E., Weipert, C. M., Zhang, N., Nilsson, M. B., Wang, K., Hong, L., Wang, J., et al. (2026) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2026.103948 · Cited by 4
Kagawa, K., Masuda, T., Shimoji, K., Yamaguchi, K., Sakamoto, S., Horimasu, Y., Nakashima, T., Iwamoto, H., Hamada, H., & Hattori, N. (2025) · Cancer Reports · doi:10.1002/cnr2.70420 · Cited by 1
Morinaga, D., Furuta, M., Morita, S., Miyauchi, E., Kobayashi, K., Maemondo, M., & Asahina, H. (2025) · Clinical Lung Cancer · doi:10.1016/j.cllc.2025.08.012 · Cited by 3
Mamesaya, N., Mori, K. P., Kobayashi, H., Omori, S., Ko, R., Wakuda, K., Ono, A., Kenmotsu, H., Naito, T., Murakami, H., et al. (2025) · International Journal of Clinical Oncology · doi:10.1007/s10147-025-02826-x · Cited by 1
Shigematsu, L., Tani, T., Ikemura, S., Ohgino, K., Horiuchi, K., Shinozaki, T., Nukaga, S., Terai, H., Sato, T., Naoki, K., et al. (2025) · Thoracic Cancer · doi:10.1111/1759-7714.70179 · Cited by 1
Self-citationHuang, D. D.-R., & Yang, J. C. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-25-00625 · Cited by 1
2025 Update: Cutting-Edge Molecular Targeted Treatments
Kunimasa, K. (2025) · Haigan · doi:10.2482/haigan.65.852
Zhang, C., Deng, R., Zhang, W., Liu, Z., Chen, F., Wu, J., & Yang, R. (2026) · BMC Cancer · doi:10.1186/s12885-026-15887-6 · Cited by 2
Monaca, F., Gomez-Randulfe, I., Heymach, J. V., Zhou, C., Addeo, A., Le, X., & Califano, R. (2026) · Journal of Clinical Oncology · doi:10.1200/jco-26-00556
Zhang, W., Deng, R., Wang, F., Chengkun, D., Mu, L., Wang, Z., Zhao, Y., Chen, F., Xu, H., Wang, J., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10604240/v1
Farinea, G., Mogavero, A., Vitale, A., Roca, E., Scotti, V., Delmonte, A., Veccia, A., Reale, M. L., Bironzo, P., Genova, C., et al. (2026) · ESMO Open · doi:10.1016/j.esmoop.2026.108369
Dempke, W. C. M., Fenchel, K., & Reinmuth, N. (2026) · Cancers · doi:10.3390/cancers18020323
Reply to: Afatinib, Dose Reduction, and Pseudo-Acute Kidney Injury
Huang, D. D.-R., & Yang, J. C. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-25-01341
Liu, D., Li, X., Yin, K., Lu, Y., Han, N., & Xu, Y. (2026) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359261442625
Yoshioka, H., Mori, M., Katakami, N., et al. (2026) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359261483551
Self-citationHigashi, T., Araya, T., Ueda, T., Hara, R., Takato, H., & Kita, T. (2026) · Cureus · doi:10.7759/cureus.107260
Recent advances in EGFR-targeted therapies for non-small cell lung cancer
Lucente, L., Barcellini, L., Pollone, B. R., Filipazzi, C. L., Coco, S., Puppo, M., Marconi, S., Santamaria, S., Tagliamento, M., Rossi, G., et al. (2026) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2026.2702380 · Cited by 1
Reply to: Afatinib, Dose Reduction, and Pseudo-Acute Kidney Injury
Miura, S. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-25-01429
Self-citationMizutani, M., Matsumoto, Y., Ohe, C., Sugimoto, A. K., Nagamine, H., Tani, Y., Oka, T., Kaneda, H., Yamada, K., Watanabe, T., et al. (2026) · Clinical Lung Cancer · doi:10.1016/j.cllc.2026.09.003
Portu, M., Martínez-Recio, S., Barba, A., González, A., López-Vilaró, L., Catasús, L., & Majem, M. (2025) · Clinical Lung Cancer · doi:10.1016/j.cllc.2025.07.013
Lu, K. J. Q., Patel, S. P., & Azenkot, T. (2026) · Clinical Lung Cancer · doi:10.1016/j.cllc.2026.05.005 · Cited by 1
Abdelhamid, S. A., El‐Shatoury, E. H., Asker, M. S., Kh, A.-E.-A. S., Attallah, A. G., Mohamed, S. S., & Elsoud, M. M. A. (2026) · Biotechnology Letters · doi:10.1007/s10529-026-03754-0 · Cited by 1
Yang, S., Ma, X., Zhao, Y., & Ma, J. (2026) · Cancer Control · doi:10.1177/10732748261481943
Metadata
- Authors
- Miura, S., Tanaka, H., Misumi, T., Yoshioka, H., Tokito, T., Fukuhara, T., Sato, Y., Shiraishi, Y., Naoki, K., Akamatsu, H., Yamaguchi, O., Yokoyama, T., Kuyama, S., Nishino, K., Furuya, N., Kurata, T., Kato, T., Ikeda, S., Horinouchi, H., Ichihara, E., Mori, M., Takiguchi, Y., Tanaka, K., Goto, Y., Okamoto, H., & on behalf of the Thoracic Oncology Research Group and all ACHILLES investigators
- Affiliations
- Niigata Cancer Center Hospital (JP)
- Chiba East Hospital (JP)
- Kansai Medical University Hospital (JP)
- Kurume University (JP)
- Miyagi Prefectural Hospital Organization (JP)
- Kobe City Medical Center General Hospital (JP)
- Kyushu University (JP)
- Kitasato University (JP)
- Wakayama Medical University (JP)
- Saitama International Medical Center (JP)
- Kurashiki Central Hospital (JP)
- Iwakuni Medical Center (JP)
- Osaka International Cancer Institute (JP)
- St. Marianna University School of Medicine (JP)
- Kanagawa Cancer Center (JP)
- Kanagawa Cardiovascular and Respiratory Center (JP)
- National Cancer Center Hospital (JP)
- Okayama University Hospital (JP)
- Toneyama National Hospital (JP)
- Chiba University Hospital (JP)
- Kagoshima University (JP)
- Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake-shi, Japan
- Yokohama Municipal Citizen's Hospital (JP)
- Corresponding author
- Miura, Satoru
- ORCID
- Miura, Satoru
- Tanaka, Hiroshi
- Misumi, Toshihiro
- Yoshioka, Hiroshige
- Tokito, Takaaki
- Fukuhara, Tatsuro
- Sato, Yuki
- Shiraishi, Yoshimasa
- Naoki, Katsuhiko
- Akamatsu, Hiroaki
- Yamaguchi, Ou
- Yokoyama, Toshihide
- Kuyama, Shoichi
- Nishino, Kazumi
- Furuya, Naoki
- Kurata, Takayasu
- Kato, Terufumi
- Ikeda, Satoshi
- Horinouchi, Hidehito
- Ichihara, Eiki
- Takiguchi, Yuichi
- Tanaka, Kentaro
- Goto, Yasuhiro
- Okamoto, Hiroaki
- Venue
- Journal of Clinical Oncology
- Published
- 2025-06-20
- Volume
- 43
- Issue
- 18
- Pages
- 2049-2058
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W4409487612
- Semantic Scholar
- 97ac64d903ae553303d79e1f74347c1564dbe7e5
- Cited by
- 37
- References
- 23
- Citations by year
- 2026: 22 · 2025: 15
- FWCI
- 24.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (22K07175)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Keywords
- afatinib, non-small cell lung cancer, EGFR mutation, uncommon EGFR mutations, EGFR tyrosine kinase inhibitors, platinum-pemetrexed chemotherapy, progression-free survival, early trial termination, G719X, L861Q, S768I, compound EGFR mutations, treatment-naive patients
- MeSH terms
- Pemetrexed, Afatinib, Progression-Free Survival, Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Non-Small-Cell Lung, Cisplatin, Female, Humans, Lung Neoplasms, Male, Middle Aged, Mutation, Carboplatin, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.